Nextech V Oncology S.C.S., SICAV-SIF SC 13G Kinnate Biopharma / Nextech V Oncology S.C.S., SICAV-SIF ownership change

CUSIP No. 49705R 10 5 13G Exhibit 99.1

JOINT FILING STATEMENT

We, the undersigned, hereby express our agreement that the attached statement on Schedule 13G relating to the Common Stock of Kinnate Biopharma Inc. is filed on behalf of each of us.

Dated: February 16, 2021

 Nextech V Oncology S.C.S., SICAV-SIF

By:	Nextech V GP S.à r.l.
Its:	General Partner

By:	/s/ Dalia Bleyer
	Dalia Bleyer, Managing Member
By:	/s/ Thomas Lips
	Thomas Lips, Managing Member

Nextech V GP S.à r.l.
By:	/s/ Dalia Bleyer
	Dalia Bleyer, Managing Member
By:	/s/ Thomas Lips
	Thomas Lips, Managing Member

/s/ Thomas Lips

Thomas Lips

/s/ Dalia Bleyer

Dalia Bleyer